Urologic Oncology Fellowship

Program Description

The Fellowship Program in Urologic Oncology in UT Southwestern’s Department of Urology is designed for additional specialized training in both the clinical and research aspects of urologic oncology. The Program is offered to U.S. residents completing their training who seek careers in academic urologic oncology.

The Program is marked by a high volume of open and minimally invasive management of prostate, bladder, testes, renal, penile, and urethral malignancies. In addition, this Fellowship Program features clinical and research experience with options in basic science, clinical trial design, and clinical outcomes research. 

The Program, which is currently approved as a Society of Urologic Oncology-accredited fellowship, offers a single two-year position each year. In the first year, the fellow immerses him/herself in research aspects of urologic oncology.

 Hospital Statistics

UT Southwestern 
University Hospitals 

Parkland Memorial Hospital

Dallas Veterans
Affairs Medical Center 

Total

 Yearly

958

256

226

1,540

 Major

607

132

112

851

 Minor

351

124

114

589

Number of Urologic
Oncology Outpatient Visits
Yearly

2,594

672

452

3,718

Research Program

The fellow may take a university graduate course in qualitative techniques such as biostatistics or research design in the Department of Clinical Sciences. Laboratories in the Department of Urology offer the fellow important opportunities to participate in research, which are centered on:

  • Signal networking in prostate cancer
  • Prostate stem cell
  • Small molecule therapy
  • Mechanisms of resistance in Androgen independent prostate cancer
  • Bladder cancer gene therapy
  • Epithelial mesenchymal transition in renal tumors

In addition, the many well-funded laboratories at the Harold C. Simmons Cancer Center are available as options for basic science research for the genitourinary (GU) oncology fellow.

The fellow also has access to a number of mature prospective databases that will allow him/her to investigate a number of GU oncology outcomes. Additionally, more than 20 active studies in the clinical research program are ongoing, including a number of investigator-initiated clinical trials in urologic oncology. These include a biomarker-based adjuvant chemotherapy trial in bladder cancer. The clinical research program also offers the GU oncology fellow the opportunity to become involved in clinical trials design. 

Clinical Program

The clinical program is supervised by the Urologic Oncology faculty. Surgeries take place at UT Southwestern University Hospitals—William P. Clements Jr. University Hospital and Zale Lipshy University Hospitalthe Dallas Veterans Affairs Medical Center, and Parkland Memorial Hospital.

In all cases, the fellow will have direct supervision from an attending. In some instances, while under attending supervision, the fellow will have the opportunity to guide the resident in the outpatient setting.

The fellow will be expected to develop necessary skills to participate in collaborative and translational work. This will be facilitated through regular conferences at the Simmons Cancer Center, Parkland, and UT Southwestern.

In addition, our weekly multimodality meetings on Mondays, which are attended by Medical Oncology, Radiation Oncology, and Urologic Oncology, offer an interactive discussion of the management of each patient with urologic malignancies.

Month 1
Week 3

Monday
morning

Surgery – Minimally invasive treatment of GU malignancy with a focus on renal and prostate malignancies (UTSW/Dallas VA)

 

Monday
afternoon

Introduction to clinical trials with a focus on study design and its application in the hospital setting (two hours)

 

 

GU Multimodality Conference
GU Disease Oriented Team Meeting
Review of Clinical Trials

 

Tuesday
morning

Surgery – Minimally invasive treatment of GU malignancy with a focus on renal and prostate malignancies (UTSW)

 

Tuesday
afternoon

Outpatient clinical focus on urologic malignancies (Urology/Raj)

 

 

Urology Surgical Planning Committee
Didactic Conference

 

Wednesday
morning

Grand Rounds

 

Wednesday

Inpatient surgery at Parkland with emphasis on complex urologic malignancies

 

Thursday
morning

Inpatient surgery with emphasis on bladder and testicular cancer treatments. Includes radical cystectomy with continent urinary diversions and complex retroperitoneal lymph node dissections (UTSW)

 

Thursday
afternoon

Outpatient clinical focus on prostate cancer treatment options (Medical Oncology/Arriaga)

 

Friday
morning

Cancer Center Combined Multimodality Conference

 

Friday

Inpatient surgery with focus on minimally invasive urologic malignancies (UTSW/Dallas VA)